Healthcare -
Biotechnology - NASDAQ - US
$ 19.935
-0.722 %
$ 1.58 B
Market Cap
-4.61
P/E
VRDN - TOTAL EQUITY
Total Equity VRDN - Viridian Therapeutics, Inc.
442 M
LAST VALUE
53.45%
2 YEAR CAGR
53.81%
5 YEAR CAGR
71.34%
10 YEAR CAGR